Home
Activity Overview
Related Articles
Volume 9 Issue 3 | Blood Advances | American Society of Hematology
Blood Advances | 9 | 3 | February 2025
Anesthetic Considerations for Gynecologic High Dose Rate Brachytherapy
High dose rate (HDR) brachytherapy is an essential component in the curative treatment for many gynecologic (gyn) cancers, including cervical cancer, uterine cancer, vaginal cancer,…
World Cancer Day 2025: A symbol of personal and collective uncertainty – The Cancer Letter
My entire life I was told to respectfully question anything and everything, because questions equal answers, which provide understanding and thereby comfort—even with the uncomfortable.…
Nurse-Led Counseling, Care Reduced Complications Following Gastric Cancer Surgery – Oncology Nurse Advisor
In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.
Serial CTRS Receives FDA Breakthrough Device Designation for NSCLC Prognosis
Serial CTRS, an AI-powered tool, has been granted FDA breakthrough device designation for classifying patients with NSCLC.
How to Choose Effective SEO Keywords for Your Research Article | How to Write a Journal Article
Find 5 helpful tips about using keywords in your research article to help journals, and your article, be found more easily by researchers.
Welcome! You are invited to join a webinar: ARC Talks Webinar: Amyloidosis 101. After registering, you will receive a confirmation email about joining the webinar.
Join us for an ARC Talks webinar to explore the basics of amyloidosis. Dr. Sarah Cuddy, cardiologist at Brigham and Women’s Hospital, will present an…
February 2025 decisions news release
10 February 2025 The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday, February 10) published advice…
Fox Chase Cancer Center Researchers Review Guidelines for Therapies Given to Melanoma Patients Before and After Initial Treatment
A team of colleagues at Fox Chase Cancer Center recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for…
Safety & efficacy of obe-cel in R/R ALL: updated findings from the FELIX trial
In this video, Pere Barba, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, shares updated results from the FELIX trial (NCT04404660), which is evaluating the…
